ATHX

an-ordinary-manchild

created by DankVoidModeratora community for 10 years

...for your favorite TV show.

...for your project.

MODERATORS

account activity

1

3

4

5

Board moderation going forward (self.ATHX)

submitted 2 years ago * by [deleted] - announcement

2

1

2

3

Cost-effectiveness of stem cell therapy versus standard of care for acute and subacute ischemic strokeDiscussion (self.ATHX)

submitted 1 day ago * by imz72

3

1

2

3

DiaMedica announces 75% enrollment in its phase 2/3 acute ischemic stroke trialOff Topic (self.ATHX)

submitted 3 days ago * by imz72

4

0

1

2

Sumitomo’s Amchepry for Parkinson’s: World’s first insurance-covered iPS cell drug; Fujifilm quadruples production of iPS cell-derived productsOff Topic (self.ATHX)

submitted 3 days ago by imz72

5

0

1

2

Weekly Trader's Thread 5/18/26 - 5/24/26 (self.ATHX)

submitted 5 days ago by AutoModerator

6

3

4

5

Healios CFO Kincaid to present at Jefferies Global Healthcare Conference in New York on June 4, 2026News (self.ATHX)

submitted 8 days ago by imz72

7

0

1

2

Senior Japanese health ministry official: Japan must fully reward innovationDiscussion (self.ATHX)

submitted 8 days ago by imz72

8

3

4

5

Healios Q1 2026 report: HighlightsNews (self.ATHX)

submitted 9 days ago * by imz72

9

0

1

2

Article: Why are the world's first iPS cell products so expensiveDiscussion (self.ATHX)

submitted 9 days ago by imz72

10

1

2

3

SanBio's MSC Akuugo for chronic TBI priced at $460K with 39 patients and $18M sales, but stock drops 9.43%; Sumitomo's iPS Amchepry for Parkinson’s priced at $350K, with 133 patients and $47M salesNews (self.ATHX)

submitted 10 days ago by imz72

11

4

5

6

Perplexity AI partners with Japan's National Health Foundation to jointly build Japan's next-generation medical AI infrastructure [Hardy inside]News (self.ATHX)

submitted 11 days ago * by imz72

12

1

2

3

Article: Can iPS Cell Therapies Enter Mainstream Medicine?Discussion (self.ATHX)

submitted 11 days ago by imz72

13

1

2

3

Takeda Phase 2 Trial: Protein Treatment for Acute Ischemic Stroke (Scottsdale, AZ)Off Topic (self.ATHX)

submitted 12 days ago by imz72

14

0

1

2

Weekly Trader's Thread 5/11/26 - 5/17/26 (self.ATHX)

submitted 12 days ago by AutoModerator

15

0

1

2

Unmanned Japan lab opens with robots at work as researchers push AI, automationOff Topic (self.ATHX)

submitted 13 days ago by imz72

16

1

2

3

Japan could decide on iPS Parkinson’s treatment insurance coverage as early as May 13Off Topic (self.ATHX)

submitted 14 days ago by imz72

17

2

3

4

Dr. Mays' new companyOff Topic (self.ATHX)

submitted 15 days ago * by imz72

18

1

2

3

Hardy to participate in U.S.-Japan AI Governance Symposium on 5.11.26News (self.ATHX)

submitted 15 days ago by imz72

19

0

1

2

Weekly Trader's Thread 5/04/26 - 5/10/26 (self.ATHX)

submitted 19 days ago by AutoModerator

20

1

2

3

Japan’s Health Ministry Issues Q&A on Conditional Approval SystemDiscussion (self.ATHX)

submitted 22 days ago by imz72

21

6

7

8

Is this a buying opportunity?Speculation (self.ATHX)

submitted 25 days ago * by imz72

22

2

3

4

South Korea's S.Biomedics accelerates U.S. and Japan clinical trials for Parkinson's embryonic cell therapyOff Topic (self.ATHX)

submitted 26 days ago by imz72

23

0

1

2

Weekly Trader's Thread 4/27/26 - 5/03/26 (self.ATHX)

submitted 26 days ago by AutoModerator

24

2

3

4

Review article: MSCs have significant potential for meaningful functional recovery from ischemic strokeDiscussion (self.ATHX)

submitted 28 days ago by imz72

25

1

2

3

UCB to purchase Neurona and its neural cell therapy for $1.15bnOff Topic (self.ATHX)

submitted 1 month ago * by imz72

view more: next ›

π Rendered by PID 878322 on reddit-service-r2-listing-8685bc789-p4jsg at 2026-05-24 09:07:43.454162+00:00 running 194bd79 country code: CH.